Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-21,130
Closed -$1.3M 743
2018
Q4
$1.3M Hold
21,130
0.02% 331
2018
Q3
$1.74M Sell
21,130
-3,800
-15% -$302K 0.02% 378
2018
Q2
$1.95M Buy
24,930
+19,300
+343% +$1.5M 0.03% 362
2018
Q1
$415K Sell
5,630
-3,000
-35% -$213K 0.01% 746
2017
Q4
$589K Sell
8,630
-20,100
-70% -$1.3M 0.01% 659
2017
Q3
$1.77M Sell
28,730
-2,300
-7% -$141K 0.03% 340
2017
Q2
$1.95M Sell
31,030
-40,030
-56% -$2.28M 0.06% 313
2017
Q1
$3.95M Buy
71,060
+35,530
+100% +$1.83M 0.04% 386
2016
Q4
$1.7M Hold
35,530
0.04% 314
2016
Q3
$2.3M Buy
35,530
+2,300
+7% +$129K 0.06% 241
2016
Q2
$1.53M Sell
33,230
-56,100
-63% -$2.26M 0.04% 368
2016
Q1
$3.42M Buy
89,330
+41,800
+88% +$1.38M 0.09% 153
2015
Q4
$1.8M Hold
47,530
0.05% 326
2015
Q3
$1.96M Buy
47,530
+42,700
+884% +$1.83M 0.05% 300
2015
Q2
$228K Hold
4,830
0.01% 889
2015
Q1
$291K Hold
4,830
0.01% 821
2014
Q4
$211K Hold
4,830
﹤0.01% 880
2014
Q3
$217K Sell
4,830
-15,600
-76% -$830K ﹤0.01% 890
2014
Q2
$1.51M Sell
20,430
-9,700
-32% -$764K 0.05% 391
2014
Q1
$2.5M Buy
30,130
+17,150
+132% +$1.51M 0.08% 248
2013
Q4
$1.79M Sell
12,980
-15,020
-54% -$1.77M 0.07% 294
2013
Q3
$2.68M Sell
28,000
-800
-3% -$67.9K 0.11% 202
2013
Q2
$1.76M Buy
+28,800
New +$1.6M 0.08% 269

Other funds holding NUS

Barings's NUS Position: Q1 2019 in Review

Barings sold out of Nu Skin (NUS) in Q1 2019, closing a stake of 21,130 shares — an estimated $1.3M sold.

Barings first reported a position in NUS in Q2 2013 and held it in 23 quarters. The position peaked at $3.95M in Q1 2017. 277 funds tracked by Wall St. Rank hold NUS as of Q1 2019.

  • Barings reported no remaining Nu Skin position as of Q1 2019 after selling out during the quarter.
  • Barings sold 21,130 Nu Skin shares in Q1 2019, an estimated $1.3M.
  • Barings first reported a position in Nu Skin in Q2 2013 and held it in 23 quarters.
  • Barings's Nu Skin position peaked at $3.95M in Q1 2017.
  • 277 funds tracked by Wall St. Rank held Nu Skin as of Q1 2019.

Based on Barings's 13F filing for Q1 2019, filed 8 May 2019.